Palo Alto Investors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-1,611,787
| Closed | -$8.37M | – | 47 |
|
2024
Q3 | $8.37M | Sell |
1,611,787
-3,645,299
| -69% | -$18.9M | 1.09% | 19 |
|
2024
Q2 | $13.5M | Buy |
5,257,086
+9,082
| +0.2% | +$23.3K | 1.57% | 13 |
|
2024
Q1 | $25.8M | Buy |
5,248,004
+10,720
| +0.2% | +$52.7K | 2.91% | 12 |
|
2023
Q4 | $46M | Buy |
5,237,284
+8,675
| +0.2% | +$76.3K | 4.15% | 8 |
|
2023
Q3 | $60M | Hold |
5,228,609
| – | – | 5.67% | 7 |
|
2023
Q2 | $132M | Sell |
5,228,609
-41,600
| -0.8% | -$1.05M | 10.69% | 3 |
|
2023
Q1 | $170M | Sell |
5,270,209
-13,400
| -0.3% | -$432K | 14.06% | 2 |
|
2022
Q4 | $97.5M | Buy |
5,283,609
+878,570
| +20% | +$16.2M | 8.32% | 7 |
|
2022
Q3 | $119M | Hold |
4,405,039
| – | – | 9.4% | 5 |
|
2022
Q2 | $60.9M | Sell |
4,405,039
-10,650
| -0.2% | -$147K | 5.31% | 8 |
|
2022
Q1 | $86.1M | Buy |
4,415,689
+46,323
| +1% | +$903K | 6.66% | 7 |
|
2021
Q4 | $71.3M | Buy |
4,369,366
+1,167,500
| +36% | +$19.1M | 4.56% | 9 |
|
2021
Q3 | $89.2M | Hold |
3,201,866
| – | – | 5.38% | 9 |
|
2021
Q2 | $94.9M | Hold |
3,201,866
| – | – | 5.23% | 8 |
|
2021
Q1 | $89.5M | Buy |
3,201,866
+528,553
| +20% | +$14.8M | 5.1% | 8 |
|
2020
Q4 | $75.8M | Buy |
2,673,313
+678,408
| +34% | +$19.2M | 3.97% | 10 |
|
2020
Q3 | $50.2M | Buy |
1,994,905
+290,533
| +17% | +$7.3M | 2.75% | 12 |
|
2020
Q2 | $41.6M | Buy |
1,704,372
+1,088,667
| +177% | +$26.6M | 2.5% | 15 |
|
2020
Q1 | $9.11M | Buy |
615,705
+527,115
| +595% | +$7.8M | 0.76% | 20 |
|
2019
Q4 | $1.44M | Buy |
+88,590
| New | +$1.44M | 0.08% | 28 |
|
2014
Q4 | – | Sell |
-80,369
| Closed | -$1.55M | – | 48 |
|
2014
Q3 | $1.55M | Sell |
80,369
-11,300
| -12% | -$218K | 0.12% | 38 |
|
2014
Q2 | $3.12M | Hold |
91,669
| – | – | 0.23% | 36 |
|
2014
Q1 | $2.89M | Buy |
+91,669
| New | +$2.89M | 0.24% | 29 |
|